Beacon Investment Advisory Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Beacon Investment Advisory Services's NVO Position: Q2 2026 in Review
Beacon Investment Advisory Services reduced its Novo Nordisk (NVO) stake by 3.9% in Q2 2026, selling an estimated $253K and leaving 145,810 shares worth $6.99M. The position accounts for 0.26% of the portfolio, ranked #83.
Beacon Investment Advisory Services first reported a position in NVO in Q3 2019 and has held it in 28 quarters since. The position peaked at $43.8M in Q2 2024. 1,355 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Beacon Investment Advisory Services held 145,810 shares of Novo Nordisk worth $6.99M as of Q2 2026.
- Beacon Investment Advisory Services sold 5,879 Novo Nordisk shares in Q2 2026, an estimated $253K.
- Novo Nordisk made up 0.26% of Beacon Investment Advisory Services's portfolio in Q2 2026, its #83 holding.
- Beacon Investment Advisory Services first reported a position in Novo Nordisk in Q3 2019 and has held it in 28 quarters since.
- Beacon Investment Advisory Services's Novo Nordisk position peaked at $43.8M in Q2 2024.
- 1,355 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Beacon Investment Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.